Qu Biologics Begins Phase 2 Clinical Trial in Crohn’s Disease VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a Vancouver, Canada-based biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique...

Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent Clinical Insights of Wistar Institute, University of Pennsylvania PHILADELPHIA, July 8, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced execution of an agreement to seek South African government approval...

Inspiring New Documentary Short "Fire With Fire" Helps Spread Awareness About Groundbreaking Advance in Cancer Treatment New York, NY, Dec. 13, 2012 (GLOBE NEWSWIRE) -- Who would dare to pit one fatal disease against another… inside the body of a seven-year-old patient? Immunologist Dr. Carl June is achieving...